| USD ($) $ in Thousands | LTM | Jan 31, 2026 | Jan 31, 2025 | Jan 31, 2024 | Jan 31, 2023 | Jan 31, 2022 | Jan 31, 2021 | Jan 31, 2020 |
|---|---|---|---|---|---|---|---|---|
Operating activities | ||||||||
Net income (loss) | $ 78,745 | $ (161,165) | $ (16,596) | $ 90,585 | ||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 290,981 | 250,218 | 187,952 | 126,838 | ||||
Loss on disposal of fixed assets | - | - | - | - | ||||
Amortization of intangible assets | 41,662 | 31,233 | 26,004 | 18,416 | ||||
Amortization of deferred contract acquisition costs | 446,524 | 449,413 | 318,837 | 238,901 | ||||
Non-cash operating lease cost | 18,851 | 17,197 | 15,283 | 13,398 | ||||
Change in fair value of redeemable convertible preferred stock warrant liability | - | - | - | - | ||||
Provision for bad debts | - | - | - | - | ||||
Stock-based compensation expense | 1,230,539 | 1,096,679 | 865,421 | 631,519 | ||||
Deferred income taxes | (19,539) | (14,797) | (9,903) | (3,387) | ||||
Realized gains on strategic investments | (40,523) | (4,161) | (6,321) | (3,936) | ||||
Gain on sale of debt securities, net | - | - | - | - | ||||
Gain on debt and equity securities, net | - | - | - | - | ||||
Accretion of short-term investments purchased at a discount | - | 0 | 2,285 | (2,285) | ||||
Non-cash interest expense | 4,034 | 5,444 | 3,763 | 3,173 | ||||
Other non-cash charges | - | - | - | - | ||||
Change in fair value of strategic investments | 0 | 1,579 | 1,000 | 1,459 | ||||
Changes in operating assets and liabilities, net of impact of acquisitions | ||||||||
Accounts receivable, net | (150,353) | (232,528) | (274,219) | (217,699) | ||||
Deferred contract acquisition costs | (750,521) | (703,707) | (584,484) | (371,649) | ||||
Prepaid expenses and other assets | (251,168) | (206,157) | (190,232) | (102,520) | ||||
Accounts payable | (5,674) | (11,267) | 84,939 | (18,898) | ||||
Accrued expenses and other liabilities | 21,789 | 22,587 | 218,518 | 14,586 | ||||
Accrued payroll and benefits | 114,935 | 61,610 | 85,873 | 65,102 | ||||
Operating lease liabilities | (14,666) | (13,692) | (15,657) | (14,035) | ||||
Deferred revenue | 1,000,999 | 1,023,863 | 669,264 | 696,639 | ||||
Other liabilities | - | - | - | - | ||||
Net cash provided by operating activities | 2,016,615 | 1,612,349 | 1,381,727 | 1,166,207 | ||||
Investing activities | ||||||||
Purchases of property and equipment | (407,897) | (302,108) | (254,852) | (176,529) | ||||
Capitalized internal-use software and website development costs | (83,115) | (68,751) | (58,969) | (49,457) | ||||
Purchases of strategic investments | (12,750) | (10,767) | (19,702) | (17,177) | ||||
Proceeds from sales of strategic investments | 18,333 | 5,217 | 12,507 | 2,000 | ||||
Purchases of strategic investments | - | - | - | - | ||||
Business acquisitions, net of cash and restricted cash acquired | (1,263,644) | (382,268) | (310,257) | (239,030) | ||||
Purchases of intangible assets | - | 0 | 0 | (11,126) | ||||
Purchases of short-term investments | 0 | 0 | 0 | (195,581) | ||||
Proceeds from maturities and sales of short-term investments | - | 0 | 97,300 | 348,281 | ||||
Purchases of investments | - | - | - | - | ||||
Proceeds from sales of investments | - | - | - | - | ||||
Purchases of deferred compensation investments | (7,577) | (6,009) | (2,721) | (2,031) | ||||
Proceeds from the sale of deferred compensation investments | 207 | 207 | 106 | - | ||||
Purchases of marketable securities | - | - | - | - | ||||
Proceeds from sales of marketable securities | - | - | - | - | ||||
Maturities of marketable securities | - | - | - | - | ||||
Net cash used in investing activities | (1,759,477) | (764,479) | (536,588) | (340,650) | ||||
Financing activities | ||||||||
Proceeds from the issuance of common stock upon initial public offering, net of underwriting discounts | - | - | - | - | ||||
Repayment of loan payable | - | - | 0 | 0 | ||||
Proceeds from revolving line of credit | - | - | - | - | ||||
Payments of debt issuance costs related to revolving line of credit | - | - | - | 0 | ||||
Payments of debt issuance costs related to Senior Notes | - | - | - | 0 | ||||
Proceeds from issuance of Senior Notes, net of debt financing costs | - | - | - | - | ||||
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs | - | - | - | - | ||||
Issuance of notes receivable to related parties | - | - | - | - | ||||
Repayment of notes receivable from related parties | - | - | - | - | ||||
Payments of contingent consideration | - | - | - | - | ||||
Payments of indemnity holdback | - | - | - | - | ||||
Repurchase of stock options | - | - | - | - | ||||
Payments of deferred offering costs | - | - | - | - | ||||
Proceeds from issuance of common stock upon exercise of stock options | 2,477 | 3,163 | 3,983 | 8,695 | ||||
Proceeds from the issuance of common stock upon exercise of early exercisable stock options | - | - | - | - | ||||
Proceeds from issuance of common stock under the employee stock purchase plan | 137,836 | 125,834 | 99,616 | 76,375 | ||||
Distributions to non-controlling interest holders | (24,995) | (2,545) | (4,891) | - | ||||
Settlement related to stockholder short-swing trade profit | - | - | - | - | ||||
Capital contributions from non-controlling interest holders | 4,500 | 6,000 | 8,500 | 8,088 | ||||
Net cash provided by financing activities | (55,804) | 132,452 | 107,208 | 93,158 | ||||
Effect of foreign exchange rates on cash, cash equivalents, and restricted cash | 1,418 | 9,629 | (5,278) | 1,958 | ||||
Net increase in cash, cash equivalents, and restricted cash | 202,752 | 989,951 | 947,069 | 920,673 | ||||
Supplemental disclosure of cash flow information: | ||||||||
Interest paid | 22,500 | 22,500 | 22,500 | 22,500 | ||||
Income taxes paid, net of refunds received | 61,658 | 51,464 | 19,022 | 22,608 | ||||
Supplemental disclosure of non-cash investing and financing activities: | ||||||||
Contingent consideration associated with business combinations | - | - | - | - | ||||
Conversion of redeemable convertible preferred stock to common stock | - | - | - | - | ||||
Conversion of redeemable convertible preferred stock warrant liabilities reclassified to additional paid-in capital | - | - | - | - | ||||
Net decrease in deferred offering costs, accrued but not paid | - | - | - | - | ||||
Net increase (decrease) in property and equipment included in accounts payable and accrued expenses | 39,000 | (5,218) | 9,452 | (3,081) | ||||
Accretion of redeemable convertible preferred stock | - | - | - | - | ||||
Vesting of early exercised stock options | - | - | 0 | 0 | ||||
Equity consideration for acquisitions | 25,251 | 2,302 | 1,155 | 652 | ||||
Debt financing costs, accrued but not paid | - | - | - | - | ||||
Operating lease liabilities arising from obtaining operating right-of-use assets | 21,200 | 40,895 | 6,821 | 16,445 | ||||
Proceeds from sales of strategic investments not yet received | 8,898 | 9,161 | 4,992 | 8,774 | ||||
Stock-based compensation included in capitalized software development costs and fixed assets | 65,324 | 56,956 | 36,959 | 31,919 | ||||
Noncash consideration for the purchase of strategic investments | 0 | 1,101 | 3,319 | - | ||||
Noncash consideration received from sales of strategic investments | - | 0 | 3,319 | - | ||||
Fair value of common stock to be issued for consideration transferred | 10,318 | 10,318 | - | - | ||||
Restricted cash held in escrow for purchase consideration for business combinations | - | $ 82,500 | - | - |